Aytu BioPharma (STU:AY20) Tax Rate % : 27.04% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aytu BioPharma Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Aytu BioPharma's Tax Expense for the three months ended in Sep. 2024 was €0.37 Mil. Aytu BioPharma's Pre-Tax Income for the three months ended in Sep. 2024 was €1.35 Mil. Therefore, Aytu BioPharma's Tax Rate % for the quarter that ended in Sep. 2024 was 27.04%.

Aytu BioPharma Tax Rate % Historical Data

The historical data trend for Aytu BioPharma's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Tax Rate % Chart

Aytu BioPharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Tax Rate %

Get a 7-Day Free Trial

-0.45

0.10

-12.56

Aytu BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Rate %	Get a 7-Day Free Trial															-	136.02	-9.26	-17.73	27.04

Aytu BioPharma Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Aytu BioPharma's Tax Rate % for the fiscal year that ended in Jun. 2024 is calculated as

Tax Rate %	=	Tax Expense (A: Jun. 2024 )	/	Pre-Tax Income (A: Jun. 2024 )
	=	1.642	/	-13.077
	=	-12.56 %

Aytu BioPharma's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Sep. 2024 )	/	Pre-Tax Income (Q: Sep. 2024 )
	=	0.365	/	1.35
	=	27.04 %

Aytu BioPharma Tax Rate % Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (STU:AY20) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

AYTU:USA 0A8M:UK

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines